INDV

#1226
Indivior Pharmaceuticals, Inc. - Common Stock
36.0 2 USD
-1.61%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
36.02
36.02
Year Range
0.37
41.00
Daily Change
-1.61%
Monthly Change
+0.06%
6 month change
+7.20%
Year Change
+7.20%
Previous Close
36.6 1
Open
36.0 2
Low
36.0 2
High
36.0 2
Volume
213
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 4.39 B
  • Employee 838
  • Founded 2014
  • CEO Mark Crossley
  • Website www.indivior.com
  • Headquarter Delaware, United States
  • FIGI BBG01ZTXFLQ6
  • Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.63
Price to sales ratio
3.02

Indivior Pharmaceuticals, Inc. - Common Stock

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

News